# AI-Generated Underwriting Reports (RAG-Augmented)

Model: XGBoost mortality prediction + SHAP + qwen2.5:7b (LangGraph agent) + traditional RAG over ChromaDB (embeddings: nomic-embed-text)


---

## Applicant 118 (predicted risk 99.4%, actual: Deceased)

1. **Underwriting Decision**: Category 'Decline' - Recommend Declining or Postponing Coverage; Refer for Medical Review.

2. **Key Risk Factors**:
   - **Age (80 years)** [1]: The applicant's advanced age significantly increases the risk of mortality, as older individuals generally have a higher baseline morbidity and reduced physiological reserve.
   - **Serum Creatinine (1.1 mg/dL) [2]**: While within the 'normal' range, this value is close to the upper limit, which may indicate subclinical renal impairment or hemodilution, both of which are associated with poor prognosis in critically ill patients.

3. **Protective Factors**:
   - None identified from the provided data.

4. **Clinical Context from Literature**:
   - **Serum Creatinine Paradox [1]**: The literature highlights that higher serum creatinine levels can paradoxically be linked to lower predicted mortality, which should not be interpreted as a protective effect. Instead, it may indicate underlying conditions such as hemodilution or reduced muscle mass.
   - **Impact of Age on Mortality Risk** [3]: Older adults have a higher risk of mortality due to their increased baseline morbidity and reduced physiological reserve.

5. **Summary Statement**: The applicant's advanced age and near-normal serum creatinine levels, which may indicate subclinical renal impairment or hemodilution, significantly increase the predicted mortality risk. Given these factors, we recommend declining or postponing coverage and referring the case for a medical review to ensure comprehensive assessment of the overall health status.

**Retrieved sources**

- [1] epmc_heart_failure_prognosis_1_PMC13276809.txt, page 0 (similarity 0.77)
- [2] epmc_blood_pressure_mortality_1_PMC13292307.txt, page 0 (similarity 0.73)
- [3] Hypertension Guideline.pdf, page 84 (similarity 0.73)
- [4] cdc_us_life_tables_2021.pdf, page 5 (similarity 0.72)

---

## Applicant 12662 (predicted risk 0.2%, actual: Alive)

1. Underwriting Decision (category + action)
   - The predicted mortality risk of 0.2% falls into a preferred category, and we recommend approving this applicant at standard rates.

2. Key Risk Factors (bulleted, most important first, with citations)
   - Age: At 27 years old, the applicant's age significantly decreases their risk [1].
   - Fasting Glucose (LBXSTR): A fasting glucose level of 3.64 mmol/L is within normal range and further decreases mortality risk [2].

3. Protective Factors
   - Waist Circumference (BMXWAIST): The waist measurement of 79.2 cm is below the threshold for metabolic syndrome, reducing the risk of associated conditions such as diabetes and cardiovascular disease [2].
   - White Blood Cell Count (LBXWBCSI): A white blood cell count of 2.03 x 10^9/L is within normal range, decreasing the risk of infection or inflammation [4].

4. Clinical Context from Literature (2-4 bullets, each with a citation)
   - The decline in life expectancy due to various causes such as COVID-19 and chronic liver disease has been observed, but improvements in other areas like influenza and pneumonia have offset some of these declines [1].
   - Waist circumference is recommended for identifying metabolic syndrome risk factors more effectively than BMI alone, highlighting the importance of abdominal obesity in this context [2].

5. Summary statement
The applicant's young age, normal fasting glucose levels, and healthy waist circumference contribute significantly to their favorable mortality risk profile, supporting an underwriting decision at standard rates. The literature underscores the importance of these factors in predicting life expectancy and overall health outcomes.

**Retrieved sources**

- [1] cdc_us_life_tables_2021.pdf, page 5 (similarity 0.72)
- [2] nhlbi_atp3_lipids_quickref.pdf, page 4 (similarity 0.71)
- [3] epmc_stroke_prognosis_1_PMC13148076.txt, page 0 (similarity 0.69)
- [4] epmc_stroke_prognosis_1_PMC13148076.txt, page 0 (similarity 0.69)

---

## Applicant 6339 (predicted risk 10.8%, actual: Alive)

1. Underwriting Decision (category + action)
   - Category: Standard. Recommended Action: Approve at standard premium rates.

2. Key Risk Factors:
   - Urinary Albumin-to-Creatinine Ratio (URXUMA): SHAP=+0.577, value=5.74 mg/mmol, increases risk [1].
   - Systolic Blood Pressure (BP_SYS_MEAN): SHAP=-1.754, value=120.5 mmHg, decreases risk but is elevated [2].

3. Protective Factors:
   - Age: SHAP=-1.754, value=42 years, decreases risk.
   - Smoking Status (SMQ020_1.0): SHAP=-0.204, value=0, decreases risk.

4. Clinical Context from Literature:
   - The urinary albumin-to-creatinine ratio (ACR) of 5.74 mg/mmol is considered elevated [1], which increases the risk for chronic kidney disease and other cardiovascular complications.
   - An elevated systolic blood pressure of 120.5 mmHg, while not yet classified as hypertension, may still be a cause for concern given its association with increased cardiovascular morbidity and mortality [2].

5. Summary statement:
The applicant's overall risk is moderate due to the presence of an elevated urinary ACR, which indicates potential kidney issues. However, other factors such as age and non-smoking status provide some protection against higher risks. The systolic blood pressure being slightly above normal also warrants attention but does not significantly alter the underwriting decision given the current mortality prediction.

**Retrieved sources**

- [1] kdigo_2024_ckd_summary_recs.pdf, page 7 (similarity 0.72)
- [2] kdigo_2024_ckd_summary_recs.pdf, page 8 (similarity 0.72)
- [3] cdc_us_life_tables_2021.pdf, page 5 (similarity 0.72)
- [4] cdc_us_life_tables_2021.pdf, page 4 (similarity 0.69)

---

## Applicant 8673 (predicted risk 10.8%, actual: Alive)

1. Underwriting Decision (category + action)
   - Category: Standard
   - Action: Approve at standard premium rates.

2. Key Risk Factors:
   - Smoking Status (SMQ020_1.0): The applicant is a current smoker, which increases the risk by 0.222 SHAP value [4].
   - Systolic Blood Pressure (LBXSTR): A systolic blood pressure of 3.47 mmHg is within normal range but slightly elevated, contributing to an increased risk by 0.563 SHAP value.
   - Waist Circumference (BMXWAIST): With a waist measurement of 73.9 cm, the applicant falls into the 'overweight' category [2], which increases the risk by 0.318 SHAP value.

3. Protective Factors:
   - Age: The age of 47 years decreases the risk significantly with an SHAP contribution of -1.257.
   - Fasting Glucose (LBXSATSI): A fasting glucose level of 2.64 mmol/L is within normal range and slightly increases the risk by 0.251 SHAP value.

4. Clinical Context from Literature:
   - The decline in life expectancy due to various causes, including chronic liver disease [1].
   - Overweight and obesity are associated with insulin resistance and metabolic syndrome, which can be identified through waist circumference measurements [2].

5. Summary statement
The overall risk is considered standard based on the mortality prediction of 10.83%, with key factors being smoking status, slightly elevated blood pressure, and a marginally increased waist circumference. These factors are balanced by protective age-related benefits. The applicant's health profile aligns well within the standard category, warranting approval at standard premium rates.

**Retrieved sources**

- [1] cdc_us_life_tables_2021.pdf, page 5 (similarity 0.72)
- [2] nhlbi_atp3_lipids_quickref.pdf, page 4 (similarity 0.71)
- [3] cdc_us_life_tables_2021.pdf, page 59 (similarity 0.69)
- [4] Blood Cholesterol Guideline.pdf, page 38 (similarity 0.68)

---

## Applicant 10891 (predicted risk 10.9%, actual: Alive)

1. Underwriting Decision (category + action)
   - Category: Standard. Recommended Action: Approve at standard premium rates.

2. Key Risk Factors:
   - Age: 57 years [1], falls within the middle-aged category, which is a significant risk factor for mortality as highlighted in the literature on life expectancy changes due to cause-specific mortality [3].
   - Urine Albumin (URXUMA): 1.33 mg/L, considered normal [4]. This value does not contribute significantly to increased risk.

3. Protective Factors:
   - Poverty Income Ratio: 5.0, decreases risk [2], indicating a higher income level.
   - Uraemic Acid Level (URDACT): 1.74, also decreases risk [2], suggesting normal levels of uremic acid which are protective against increased mortality.

4. Clinical Context from Literature:
   - The literature on life expectancy changes due to cause-specific mortality [3] indicates that age is a significant factor in reducing life expectancy.
   - The reference ranges for urine albumin [4] suggest that values within the normal range do not significantly impact mortality risk, supporting the SHAP analysis.

5. Summary statement:
The applicant's overall mortality risk is considered standard based on their predicted probability of 10.9%, with key factors including age and a normal urine albumin level. The protective factors such as a higher income level and normal uremic acid levels further support this decision, leading to approval at standard premium rates.

**Retrieved sources**

- [1] kdigo_2024_ckd_summary_recs.pdf, page 7 (similarity 0.72)
- [2] kdigo_2024_ckd_summary_recs.pdf, page 8 (similarity 0.72)
- [3] cdc_us_life_tables_2021.pdf, page 5 (similarity 0.72)
- [4] epmc_albuminuria_risk_1_PMC13292312.txt, page 0 (similarity 0.70)

---

## Applicant 17300 (predicted risk 10.9%, actual: Alive)

1. Underwriting Decision (category + action)
   The predicted mortality risk of 0.1087 corresponds to a standard underwriting category, and we recommend approving this applicant at standard premium rates.

2. Key Risk Factors:
   - **LBXSAL (Albumin):** SHAP=-0.449, value=4.9 g/dL [1] [2]. Albumin levels are inversely related to mortality risk; lower albumin values can indicate malnutrition or chronic illness, which may contribute to higher mortality rates.
   - **LBXSCR (Serum Creatinine):** SHAP=-0.324, value=0.36 mg/dL [1]. Lower serum creatinine levels are associated with a paradoxical increase in risk due to potential hemodilution or reduced muscle mass, both of which can be indicative of poor prognosis.
   - **LBXPLTSI (Platelets):** SHAP=+0.268, value=158 × 10^3/µL [1]. Elevated platelet counts are a risk factor for adverse outcomes in critically ill patients.

3. Protective Factors:
   - **AGE:** SHAP=-1.302, value=43 years old. The applicant's age is below the median and decreases the overall mortality risk.
   - **POVERTY_INCOME_RATIO:** SHAP=-0.287, value=5.0 [3]. A lower poverty-to-income ratio suggests a more stable socioeconomic status, which can be protective.

4. Clinical Context from Literature:
   - The "creatinine paradox" observed in critically ill patients (e.g., SA-AKI) indicates that lower creatinine levels may not always indicate better health but could reflect hemodilution or reduced muscle mass [1].
   - Albumin levels are a key indicator of nutritional status and overall health; lower values can be associated with increased mortality risk due to underlying chronic conditions [2].

5. Summary statement:
The applicant's overall mortality risk is moderate, primarily driven by factors such as low albumin levels and elevated platelets, but mitigated by protective factors like younger age and a more stable socioeconomic status. The literature supports the importance of these clinical markers in predicting outcomes among critically ill patients.

**Retrieved sources**

- [1] epmc_heart_failure_prognosis_1_PMC13276809.txt, page 0 (similarity 0.77)
- [2] epmc_blood_pressure_mortality_1_PMC13292307.txt, page 0 (similarity 0.73)
- [3] cdc_us_life_tables_2021.pdf, page 5 (similarity 0.72)
- [4] epmc_liver_enzymes_mortality_1_PMC13288716.txt, page 0 (similarity 0.70)

---

## Applicant 1176 (predicted risk 10.9%, actual: Alive)

1. Underwriting Decision (category + action)
   - Category: Standard
   - Action: Approve at standard premium rates.

2. Key Risk Factors:
   - Waist Circumference (BMXWAIST): 81.4 cm, which is within the normal range but slightly elevated [4]. This measurement suggests a higher risk of metabolic syndrome and associated conditions.
   - Urinary Albumin-to-Creatinine Ratio (LBXSGB): 2.4 mg/g, indicating mild albuminuria [1], [2]. This finding could suggest early-stage chronic kidney disease.

3. Protective Factors:
   - Age: 55 years old, which is a protective factor as life expectancy generally increases with age.
   - Smoking Status (SMQ020): Non-smoker, reducing the risk of several diseases including lung cancer and cardiovascular issues [3].

4. Clinical Context from Literature:
   - The waist circumference measurement of 81.4 cm is within the normal range but close to the threshold for metabolic syndrome, which can increase the risk of diabetes and cardiovascular disease [4].
   - Mild albuminuria (2.4 mg/g) as indicated by LBXSGB suggests early-stage chronic kidney disease, a condition that requires monitoring [1], [2].

5. Summary statement:
The applicant's overall mortality risk is low at 10.9%, placing them in the standard category. While there are some risk factors such as mild albuminuria and slightly elevated waist circumference, these are balanced by protective factors like age and non-smoking status. Regular monitoring for chronic kidney disease and metabolic syndrome should be recommended to ensure ongoing health.

**Retrieved sources**

- [1] kdigo_2024_ckd_summary_recs.pdf, page 7 (similarity 0.72)
- [2] kdigo_2024_ckd_summary_recs.pdf, page 8 (similarity 0.72)
- [3] cdc_us_life_tables_2021.pdf, page 5 (similarity 0.72)
- [4] nhlbi_atp3_lipids_quickref.pdf, page 4 (similarity 0.71)

---

## Applicant 16988 (predicted risk 10.9%, actual: Alive)

1. Underwriting Decision (category + action)
   - Category: Standard
   - Action: Approve at standard premium rates

2. Key Risk Factors:
   - Smoking status (SMQ020_1.0 = 1): The applicant has a history of smoking, which increases the risk of various diseases including respiratory issues and cardiovascular problems [4].
   - Elevated SARS-CoV-2 antibody level (LBXSASSI = 4.23): This suggests past exposure to SARS-CoV-2, potentially indicating a higher risk for severe outcomes from future infections or complications [1].

3. Protective Factors:
   - Age (AGE = 30.0): The applicant's young age significantly decreases the overall mortality risk, aligning with life expectancy trends observed in younger populations [1].
   - Height (BMXHT = 185.5 cm): While no specific reference range is available, this height falls within a normal adult male range and does not contribute to increased mortality risk.

4. Clinical Context from Literature:
   - The decline in life expectancy from 2020 to 2021 was primarily due to increases in mortality due to COVID-19 [1]. This context supports the elevated SARS-CoV-2 antibody level as a significant risk factor.
   - Smoking is recognized as a major contributor to increased mortality, particularly for respiratory and cardiovascular diseases [4].

5. Summary statement:
The applicant's overall health profile, with key factors such as smoking history and past exposure to SARS-CoV-2, are the primary contributors to the slightly elevated mortality risk. However, their young age provides substantial protection against premature mortality, leading to an underwriting decision of standard risk at current premium rates. Regular follow-up should be encouraged to monitor any changes in health status that could impact this assessment.

**Retrieved sources**

- [1] cdc_us_life_tables_2021.pdf, page 5 (similarity 0.72)
- [2] epmc_liver_enzymes_mortality_1_PMC13288716.txt, page 0 (similarity 0.70)
- [3] cdc_us_life_tables_2021.pdf, page 9 (similarity 0.70)
- [4] cdc_us_life_tables_2021.pdf, page 59 (similarity 0.69)